SCHEMBL4654033

SCHEMBL4654033

CCCCCCC(CO)CC(=O)O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.65
GPR84 Q9NQS5 10/20 0.60
FFAR1 O14842 3/20 0.48
FFAR4 Q5NUL3 2/20 0.48
ALDH1A1 P00352 3/20 0.48
PPARD Q03181 6/20 0.47
MAPT P10636 1/20 0.47
LCK P06239 1/20 0.47
ZDHHC20 Q5W0Z9 1/20 0.47
ZDHHC2 Q9UIJ5 1/20 0.47
PPARG P37231 5/20 0.45
PPARA Q07869 5/20 0.45
HDAC11 Q96DB2 4/20 0.45
TSHR P16473 3/20 0.45
TLR2 O60603 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
FABP4 P15090 2/20 0.45
PTPN1 P18031 2/20 0.45
SLC22A6 Q4U2R8 1/20 0.45
SLC22A8 Q8TCC7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10476357 1.00 LMNA (0.65) LMNAGPR84FFAR1FFAR4ALDH1A1
SCHEMBL27915361 1.00 LMNA (0.65) LMNAGPR84FFAR1FFAR4ALDH1A1
SCHEMBL27678299 1.00 LMNA (0.65) LMNAGPR84FFAR1FFAR4ALDH1A1
SCHEMBL27915359 1.00 LMNA (0.65) LMNAGPR84FFAR1FFAR4ALDH1A1
SCHEMBL1881443 1.00 LMNA (0.65) LMNAGPR84FFAR1FFAR4ALDH1A1
SCHEMBL27281307 1.00 LMNA (0.65) LMNAGPR84FFAR1FFAR4ALDH1A1
SCHEMBL27518246 1.00 LMNA (0.65) LMNAGPR84FFAR1FFAR4ALDH1A1
SCHEMBL317762 0.98 LMNA (0.61) LMNAGPR84FFAR1FFAR4ALDH1A1
SCHEMBL4790710 0.93 LMNA (0.57) LMNAGPR84FFAR1FFAR4ALDH1A1
SCHEMBL5104868 0.92 ALDH1A1 (0.58) LMNAGPR84FFAR1FFAR4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114787266-B Resin composition, resin-metal composite member, and tire 株式会社普利司通 2025-02-21 CN disclosed
EP-3878665-B1 TIRE BRIDGESTONE CORP (JP) 2024-01-10 EP disclosed
CN-114787266-A Resin composition, resin-metal composite member, and tire 株式会社普利司通 2022-07-22 CN disclosed
CN-111278664-B Metal-resin composite member for tire, and tire 株式会社普利司通 2022-06-10 CN disclosed
EP-3640047-B1 TIRE BRIDGESTONE CORP (JP) 2022-04-20 EP disclosed
EP-3640048-B1 TIRE BRIDGESTONE CORP (JP) 2022-04-13 EP disclosed
EP-3640050-B1 RESIN-METAL COMPOSITE MEMBER FOR TIRE, AND TIRE BRIDGESTONE CORP (JP) 2022-03-23 EP disclosed
EP-3640052-B1 RESIN-METAL COMPOSITE MEMBER FOR TIRE, AND TIRE BRIDGESTONE CORP (JP) 2022-01-19 EP disclosed
US-20210402830-A1 TIRE BRIDGESTONE CORPORATION (JP) 2021-12-30 US disclosed
EP-3878665-A1 TIRE BRIDGESTONE CORPORATION (JP) 2021-09-15 EP disclosed
US-20050124563-A1 Triazole linked carbohydrates SABESAN SUBRAMANIAM (US) 2005-06-09 US disclosed
US-6852866-B2 Triazole linked carbohydrates E. I. DU PONT DE NEMOURS AND COMPANY (US) 2005-02-08 US disclosed
US-20040067576-A1 Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same CANON KABUSHIKI KAISHA (JP) 2004-04-08 US disclosed
US-20040059105-A1 Triazole linked carbohydrates SABESAN SUBRAMANIAM (US) 2004-03-25 US disclosed
US-6649381-B1 Biosynthesis of high purity polylactones CANON KABUSHIKI KAISHA (JP) 2003-11-18 US disclosed
US-20030208029-A1 Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same CANON KABUSHIKI KAISHA (JP) 2003-11-06 US disclosed
US-6586562-B2 Polylactone with units such as of 3-hydroxy-5-(4-fluorophenyl)valeric acid; biosynthesis of the polylactone by microorganism; Pseudomonas cichorii; P. putida; P. jessenii CANON KABUSHIKI KAISHA (JP) 2003-07-01 US disclosed
US-20020022253-A1 Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same CANON KABUSHIKI KAISHA (JP) 2002-02-21 US disclosed
EP-1113033-A2 Polyhydroxyalkanoate, method for production thereof and microorganisms for use in the same CANON KABUSHIKI KAISHA (JP) 2001-07-04 EP disclosed
EP-0100158-A2 (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters THE UPJOHN COMPANY (US) 1984-02-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124563-A1 Triazole linked carbohydrates ST3GAL3, B3GAT3, FUT5 LMNA 4291/4885GPR84 2978/4885FFAR1 2816/4885
US-20040059105-A1 Triazole linked carbohydrates ST3GAL3, B3GAT3, FUT5 LMNA 4291/4885GPR84 2978/4885FFAR1 2816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.